1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Exicure, Inc.

Exicure, Inc.

XCUR
Exicure, Inc.US flagNASDAQ Capital Market
3.15
USD
+0.04
- -
20.08MMarket Cap

Income Statement (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
1
10
- -
1
17
- -
29
- -
- -
- -
+ Sales & Services Revenue
1
10
- -
1
17
- -
29
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
-1
-10
- -
-1
-17
- -
-29
- -
- -
- -
- Operating Expenses
17
20
22
28
42
62
31
13
5
10
+ Selling, General & Admin
4
7
8
9
10
13
11
12
5
7
+ Research & Development
14
13
14
19
32
49
20
1
- -
3
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-16
-10
-22
-27
-25
-63
-2
-13
-5
-10
- Non-Operating (Income) Loss
1
1
1
- -
-1
2
1
4
5
-5
+ Interest Expense, Net
1
1
1
1
- -
2
1
- -
- -
- -
+ Interest Expense
1
1
1
1
1
2
1
- -
- -
- -
- Interest Income
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
-1
- -
- -
- -
4
5
-5
Pretax Income
-17
-11
-22
-26
-25
-64
-2
-17
-10
-6
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-17
-11
-22
-26
-25
-64
-3
-17
-10
-5
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-17
-11
-22
-26
-25
-64
-3
-17
-10
-5
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-17
-11
-22
-26
-25
-64
-3
-17
-10
-5
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-17
-11
-22
-26
-25
-64
-3
-17
-10
-5
EBIT
-16
-10
-22
-27
-25
-63
-2
-13
-5
-10
EBITDA
-16
-10
-21
-26
-24
-61
- -
-12
-4
-10
EBITDA Margin (%)
-1,542.66
-104.69
-18,187.29
-1,997.92
-144.4
12,581.78
0.09
- -
-825
- -
EBITA
-16
-10
-22
-27
-25
-63
-2
-13
-5
-10
Gross Margin (%)
100
100
100
100
100
100
100
- -
100
- -
Operating Margin (%)
-1,560.04
-107.08
-18,490.68
-2,053.78
-153.11
12,950.1
-6.35
- -
-989.8
- -
Profit Margin (%)
-1,635.23
-113.29
-18,994.07
-2,029.55
-148.49
13,271.64
-8.96
- -
-1,940.2
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
2
2
1
1
- -
Basic Weighted Avg Shares
- -
- -
- -
1
1
1
1
2
2
6
Basic EPS, GAAP
-64.41
-41.86
-81.62
-45.84
-42.43
-108.5
-2.79
-10.55
-4.75
-0.79
Basic EPS from Cont Ops
-64.41
-41.86
-81.62
-45.84
-42.43
-108.5
-2.79
-10.55
-4.75
-0.79
Diluted Weighted Avg Shares
- -
- -
- -
1
1
1
1
2
2
6
Diluted EPS, GAAP
-64.41
-41.86
-81.62
-45.84
-42.43
-108.5
-2.79
-10.55
-4.75
-0.79
Diluted EPS from Cont Ops
-64.41
-41.86
-81.62
-45.84
-42.43
-108.5
-2.79
-10.55
-4.75
-0.79

Balance Sheet (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
20
28
28
113
86
44
10
2
14
5
+ Cash, Cash Equivalents & STI
20
26
26
111
82
39
9
1
13
4
+ Cash & Cash Equivalents
20
26
26
48
33
35
9
1
13
4
+ ST Investments
- -
- -
- -
62
49
4
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
2
1
2
4
5
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
1
1
2
14
21
13
10
1
9
+ Property, Plant & Equip, Net
1
1
1
2
13
12
10
7
- -
- -
+ Property, Plant & Equip
1
2
2
4
14
15
13
7
- -
1
- Accumulated Depreciation
1
1
1
1
2
3
4
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
1
9
3
3
1
9
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
1
9
3
3
1
1
Total Assets
21
29
29
115
100
65
23
12
15
14
+ Payables & Accruals
3
2
2
4
5
9
1
2
2
4
+ Accounts Payable
1
1
- -
2
2
3
- -
2
1
2
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
2
1
2
2
3
6
1
- -
1
2
+ ST Debt
1
- -
- -
5
- -
7
1
1
1
- -
+ ST Borrowings
1
- -
- -
5
- -
7
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
1
1
1
- -
+ Other ST Liabilities
8
1
- -
22
8
17
- -
- -
- -
- -
+ Deferred Revenue
8
1
- -
22
8
17
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
12
3
2
31
14
34
2
3
3
4
+ LT Debt
4
5
5
- -
25
7
7
6
5
- -
+ LT Borrowings
4
5
5
- -
17
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
8
7
7
6
5
- -
+ Other LT Liabilities
2
1
1
3
1
12
- -
- -
- -
6
+ Accrued Liabilities
1
- -
- -
3
- -
12
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
1
1
- -
1
1
- -
- -
- -
6
Total Noncurrent Liabilities
6
6
6
3
25
20
7
6
5
6
Total Liabilities
18
9
8
35
39
54
8
9
8
10
+ Preferred Equity and Hybrid Capital
43
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
-18
54
76
162
167
181
188
193
206
208
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
-18
54
76
162
167
181
188
193
206
208
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-23
-34
-55
-81
-106
-170
-173
-190
-199
-204
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
2
20
21
81
62
11
15
3
7
4
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
2
20
21
81
62
11
15
3
7
4
Total Liabilities & Equity
21
29
29
115
100
65
23
12
15
14
Shares Outstanding
- -
- -
- -
1
1
1
1
2
6
6
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
8
8
7
7
6
- -
Net Debt
-14
-21
-21
-43
-17
-28
-9
-1
-13
-4
Net Debt to Equity
-570.1
-104.68
-101.87
-53.87
-27.11
-247.25
-57.48
-26.92
-184.7
-95.42
Tangible Common Equity Ratio
-195.29
68.91
72.86
70.05
61.23
17.32
63.97
26.17
44.98
-72.67
Current Ratio
1.65
8.24
13.54
3.63
6.29
1.28
6.13
0.81
4.45
1.19
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-17
-11
-22
-26
-25
-64
-3
-17
-10
-5
+ Depreciation & Amortization
- -
- -
- -
1
1
2
2
1
1
- -
+ Non-Cash Items
1
1
3
2
2
3
2
4
5
-5
+ Stock-Based Compensation
1
1
2
2
2
3
1
1
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
6
- -
+ Other Non-Cash Adj
- -
- -
1
- -
- -
- -
1
3
- -
-5
+ Chg in Non-Cash Work Cap
11
-10
- -
25
-18
24
-37
1
1
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
-1
1
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
1
-1
-3
- -
3
1
1
- -
+ Inc (Dec) in Accts Payable
1
-1
- -
1
2
4
-8
1
1
- -
+ Inc (Dec) in Other
9
-8
- -
25
-17
20
-32
-1
-1
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-5
-20
-19
1
-39
-35
-36
-10
-3
-9
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
32
22
91
3
11
5
5
12
2
+ Increase in Capital Stock
- -
32
22
91
3
11
5
5
12
2
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
-62
13
44
5
-2
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
70
51
6
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
-62
-57
-6
-1
-2
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
-2
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
-1
- -
-1
-3
-1
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-1
- -
-63
10
43
5
-1
- -
-2
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
6
-1
- -
- -
13
-10
-8
- -
1
- -
+ Cash From Debt
6
- -
- -
- -
18
- -
- -
- -
1
- -
+ Repayments of Debt
- -
-1
- -
- -
-5
-10
-8
- -
- -
- -
+ Other Financing Activities
- -
-4
-2
-6
- -
- -
-1
-2
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
6
27
20
84
15
1
-3
4
13
2
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
1
6
1
22
-14
9
-34
-8
10
-9
EBITDA
-16
-10
-21
-26
-24
-61
- -
-12
-4
-10
EBITDA Margin (%)
-1,542.66
-104.69
-18,187.29
-1,997.92
-144.4
12,581.78
0.09
- -
-825
- -
Free Cash Flow
-5
-20
-19
1
-39
-35
-36
-10
-3
-9
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-63
-19
1
-27
-45
-43
-9
-2
-9
Free Cash Flow per Basic Share
-19.2
-75.23
-70.97
2.3
-67.55
-58.94
-38.6
-6.46
-1.42
-1.36
Price/Free Cash Flow
- -
- -
-7.48
186.91
-3.93
-0.51
-0.15
-0.45
-9.6
-3.99
Cash Flow to Net Income
0.3
1.8
0.87
-0.05
1.59
0.54
13.81
0.61
0.3
1.73
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -